Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
1,201,145
-
Shares change
-
-213,337
-
Total reported value, excl. options
-
$77,685,792
-
Value change
-
-$13,859,542
-
Number of buys
-
41
-
Number of sells
-
26
-
Price
-
$64.72
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q1 2024
As of 31 Mar 2024 INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) had 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,201,145 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, LPL Financial LLC, UBS Group AG, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, Royal Bank of Canada, Gerber Kawasaki Wealth & Investment Management, CreativeOne Wealth, LLC, Equitable Holdings, Inc., and Cetera Investment Advisers.
This table shows 106 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.